YOUNJOO JUNG

Dr. YOUNJOO JUNG

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Journal of Endocrine Surgery
Verified
Journal Article
Open access
DKDong-Il Kim
Dong-Il Kim
YJYOUNJOO JUNG
YOUNJOO JUNG
HPHyun-June Paik
Hyun-June Paik
JKJee Yeon Kim
Jee Yeon Kim
HKHyun Yul Kim
Hyun Yul Kim

26 May 2022 in World Journal of Clinical Cases
Verified
Journal Article
Open access
HKHyun Yul Kim
Hyun Yul Kim
SLSeungju Lee
Seungju Lee
DKDong-Il Kim
Dong-Il Kim
CJChang Shin Jung
Chang Shin Jung
JKJee Yeon Kim
Jee Yeon Kim
YJYOUNJOO JUNG
YOUNJOO JUNG
Metaplastic breast cancer (MBC) is a rare subtype of breast cancer. They constitute less than 1% of breast cancer cases and are much rarer in males. There are few reports of MBC because of its rarity. MBC, an aggressive type of cancer, is refractory to common treatment modalities of breast cancer and has a poor prognosis. We report a case of MBC in a 78-year-old man. He visited our clinic with a palpable mass on the left breast with no masses in the axillary areas. He had previously undergone robot-assisted laparoscopic radical prostatectomy for prostate cancer, but there was no family history of malignancy. The breast mass was visible on ultrasonography, mammography, and magnetic resonance imaging, and chest computed tomography revealed a lung mass in the posterior basal segment of the right lower lobe. The patient was diagnosed with metaplastic carcinoma on core needle biopsy with lung metastasis. Total mastectomy with sentinel lymph node biopsy and video-assisted segmentectomy of the right lung was performed. However, multiple metastases appeared 3 mo after surgery in the brain, chest, and abdomen, and the patient died 5 mo after the initial diagnosis. MBC is an aggressive and extremely rare breast cancer type. Further case reports are needed to determine the optimal treatment.

1 January 2023 in Journal of the Korean Society of Radiology
Verified
Journal Article
Open access
PDF file
YJYOUNJOO JUNG
YOUNJOO JUNG
KNKyung Jin Nam
Kyung Jin Nam
KCKi Seok Choo
Ki Seok Choo
KLKyeyoung Lee
Kyeyoung Lee
정윤주, et al. J Korean Soc Radiol. 2023 Jan;84(1):275-279. https://doi.org/10.3348/jksr.2022.0129

1 January 2025 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
SLSeungju Lee
Seungju Lee
HKHyun Yul Kim
Hyun Yul Kim
YJYOUNJOO JUNG
YOUNJOO JUNG
SKSeok-Kyung Kang
Seok-Kyung Kang
MRMiri Ryu
Miri Ryu
JKJee Yeon Kim
Jee Yeon Kim
Lee S, et al. J Breast Cancer. 2025 Nov;28:e43. https://doi.org/10.4048/jbc.2025.0165

1 June 2023 in Korean Journal of Clinical Oncology
Verified
Journal Article
Open access
PDF file
SLSeungju Lee
Seungju Lee
HKHyun Yul Kim
Hyun Yul Kim
YJYOUNJOO JUNG
YOUNJOO JUNG
SKSeok-Kyung Kang
Seok-Kyung Kang
JKJee Yeon Kim
Jee Yeon Kim
MYMi Sook Yun
Mi Sook Yun
Purpose: Several studies are concerned about the association between bone mineral density (BMD) and the risk of breast cancer in postmenopausal women, but it is controversial. Therefore, we evaluated whether BMD might be a risk factor for recurrences, or metastases in menopausal luminal A breast cancer patients.Methods: In this retrospective study, data of 348 patients with luminal A breast cancer who received treatment at Pusan National University Yangsan Hospital between 2012 and 2016 were analyzed. Patients were divided into two groups: normal BMD and low BMD including osteopenia or osteoporosis in preoperative examination. Patients were also divided into three groups according to BMD changes: no change in BMD; improvement in BMD, and deterioration in BMD. Events were defined as recurrence, occurrence of contralateral breast cancer, and metastasis to any other organ.Results: Preoperative examination revealed normal BMD in 129 of 348 patients and low BMD in 219 patients. During a median follow-up period of 78 months, only 14 patients (4.0%) experienced recurrences, distant metastases, or occurrences of contralateral breast cancer. Five-year disease-free survival rate was 98.2% for 219 patients with low BMD and 95.0% for 129 patients with normal BMD (P=0.33). Disease-free survival at 5 years was 97.0% for the no change in the BMD group, 94.6% for the BMD improvement group, and 98.4% for the BMD deterioration group (P=0.79).Conclusion: In this study, BMD had no statistically significant associations on recurrences, metastases, or incidences of contralateral breast cancer in postmenopausal patients with luminal A breast cancer.

28 August 2023 in Medicina
Verified
Journal Article
Open access
PDF file
KLKyeyoung Lee
Kyeyoung Lee
YJYeo Jin Jeong
Yeo Jin Jeong
KCKi Seok Choo
Ki Seok Choo
SNSu Bong Nam
Su Bong Nam
HKHyun Yul Kim
Hyun Yul Kim
KNKyung Jin Nam
Kyung Jin Nam
Background and Objectives: To determine the percentage of breast cancers detectable by fused diffusion-weighted imaging (DWI) using unenhanced magnetic resonance imaging (MRI) and abbreviated post-contrast-enhanced MRI. Materials and Methods: Between October 2016 and October 2017, 194 consecutive women (mean age, 54.2 years; age range, 28–82 years) with newly diagnosed unilateral breast cancer, who underwent preoperative 3.0 T breast MRI with DWI, were evaluated. Both fused DWI and abbreviated MRI were independently reviewed by two radiologists for the detection of index cancer (which showed the most suspicious findings in both breasts), location, lesion conspicuity, lesion type, and lesion size. Moreover, the relationship between cancer detection and histopathological results of surgical specimens was evaluated. Results: Index cancer detection rates were comparable between fused DWI and abbreviated MRI (radiologist 1: 174/194 [89.7%] vs. 184/194 [94.8%], respectively, p = 0.057; radiologist 2: 174/194 [89.7%] vs. 183/194 [94.3%], respectively, p = 0.092). In both radiologists, abbreviated MRI showed a significantly higher lesion conspicuity than fused DWI (radiologist 1: 9.37 ± 2.24 vs. 8.78 ± 3.03, respectively, p < 0.001; radiologist 2: 9.16 ± 2.32 vs. 8.39 ± 2.93, respectively, p < 0.001). The κ value for the interobserver agreement of index cancer detection was 0.67 on fused DWI and 0.85 on abbreviated MRI. For lesion conspicuity, the intraclass correlation coefficients were 0.72 on fused DWI and 0.82 on abbreviated MRI. Among the histopathological factors, tumor invasiveness was associated with cancer detection on both fused DWI (p = 0.011) and abbreviated MRI (p = 0.004, radiologist 1), lymphovascular invasion on abbreviated MRI (p = 0.032, radiologist 1), and necrosis on fused DWI (p = 0.031, radiologist 2). Conclusions: Index cancer detection was comparable between fused DWI and abbreviated MRI, although abbreviated MRI showed a significantly better lesion conspicuity.